Deardorff MA, Kaur M, Yaeger D, Rampuria A, Korolev S, Pie J, et al
Like weight-loss diets, semaglutide only works as long as someone is taking it
You think you are at 10, but it could be 9 or 11
BPC-157 is a synthetic pentadecapeptide stabilised against acid hydrolysis, acting through multiple receptor systems including VEGFR2, FAK (focal adhesion kinase), EGR1 (early growth response protein 1), and eNOS to produce angiogenesis, tissue repair, anti-inflammatory, and neuroprotective effects
Available in both oral and injectable forms, it offers patients flexibility in choosing a treatment that best fits their lifestyle and preferences
We set realistic expectations up front and measure against your own baseline rather than a promised result